TY - JOUR
T1 - CXCR3 antagonists: quaternary ammonium salts equipped with biphenyl- and polycycloaliphatic-anchors
AU - Wijtmans, M.
AU - Verzijl, D.
AU - Bergmans, S.
AU - Lai, M.
AU - Bosch, L.
AU - Smit, M.J.
AU - de Esch, I.J.P.
AU - Leurs, R.
PY - 2011
Y1 - 2011
N2 - Small-molecule ligands for the CXCR3 chemokine receptor receive considerable attention as a means to interrogate the roles of CXCR3 in vitro and in vivo and/or to potentially treat various conditions such as inflammatory diseases and cancer. We have synthesized and explored a novel class of small-molecule antagonists for CXCR3. A medium-throughput screen revealed an adamantane-guanidine as a hit. The guanidine unit was replaced by a small quaternary ammonium group, leading to ca. 5-fold increase in affinity. Substitution of the adamantane group by a myrtenyl moiety further increased affinity, while the benzyl group was decorated with an additional (substituted) aryl ring. This led to the identification of several bisaryl-based ligands with CXCR3 affinities of around 100 nM and with the ability to antagonize the functional activity of CXCL10. © 2011 Elsevier Ltd. All rights reserved.
AB - Small-molecule ligands for the CXCR3 chemokine receptor receive considerable attention as a means to interrogate the roles of CXCR3 in vitro and in vivo and/or to potentially treat various conditions such as inflammatory diseases and cancer. We have synthesized and explored a novel class of small-molecule antagonists for CXCR3. A medium-throughput screen revealed an adamantane-guanidine as a hit. The guanidine unit was replaced by a small quaternary ammonium group, leading to ca. 5-fold increase in affinity. Substitution of the adamantane group by a myrtenyl moiety further increased affinity, while the benzyl group was decorated with an additional (substituted) aryl ring. This led to the identification of several bisaryl-based ligands with CXCR3 affinities of around 100 nM and with the ability to antagonize the functional activity of CXCL10. © 2011 Elsevier Ltd. All rights reserved.
UR - https://www.scopus.com/pages/publications/79957493207
UR - https://www.scopus.com/inward/citedby.url?scp=79957493207&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2011.04.035
DO - 10.1016/j.bmc.2011.04.035
M3 - Article
SN - 0968-0896
VL - 19
SP - 3384
EP - 3393
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 11
ER -